ExpertiseUpdated on 23 October 2025
Machine Learning
Computer Engineer at Kedi Mobile Applications
Muğla, Türkiye
About
Seeking a Twinning partnership under the EP PerMed Twinning Call 2026 to advance AI-driven, bioinformatics-based solutions for personalised medicine. The initiative focuses on transferring expertise in multi-omics integration, predictive modelling, and data-driven decision support, accelerating the cross-border implementation of innovative precision-health technologies.
Field
- Screening & early detection programs (risk stratification, predictive tools)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Patient management systems (decision-support tools, clinical workflows)
- Recovery & follow-up support systems (digital monitoring, apps, telemedicine)
- Clinical decision support systems for personalised medicine
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
Organisation
Similar opportunities
Expertise
Offering Expertise of the group of Prof. Markus Scholz
- Clinical decision support systems for personalised medicine
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Screening & early detection programs (risk stratification, predictive tools)
Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
Expertise
Offering expertise of the group of Prof. Markus Scholz
- Clinical decision support systems for personalised medicine
- Theranostics (combined diagnostic + therapeutic approaches)
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Screening & early detection programs (risk stratification, predictive tools)
Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany
Expertise
Offering expertise of the group of Prof. Markus Scholz
- Clinical decision support systems for personalised medicine
- Diagnostic tools (biomarkers, genetic tests, companion diagnostics)
- Personalised treatment pathways (tailored therapies, precision dosing)
- Partial adoption of a PM solution (testing selected modules/components)
- Screening & early detection programs (risk stratification, predictive tools)
Peter Ahnert
Senior Scientist at Leipzig University - Medical Faculty - IMISE
Leipzig, Germany